Barclays’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-106,300
Closed -$2.95M – 5181
2024
Q1
$2.95M Buy
+106,300
New +$2.36M ﹤0.01% 2249

Other funds holding ACH

Barclays's ACH Position: Q3 2026 in Review

Barclays increased its Accendra Health (ACH) stake by 649% in Q3 2026, buying an estimated $129K and bringing the position to 74,457 shares worth $41.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4617.

Barclays first reported a position in ACH in Q2 2013 and has held it in 54 quarters since. The position peaked at $6.14M in Q1 2021. 118 funds tracked by Wall St. Rank hold ACH as of Q3 2026.

  • Barclays held 74,457 shares of Accendra Health worth $41.9K as of Q3 2026.
  • Barclays bought 64,518 Accendra Health shares in Q3 2026, an estimated $129K.
  • Accendra Health made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4617 holding.
  • Barclays first reported a position in Accendra Health in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Accendra Health position peaked at $6.14M in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Accendra Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.